Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2012 | 0 | 15.641.195 | 1.270.200 | 2 | ||
2011 | 0 | 3.974.000 | 513.506 | 1 | ||
2010 | 0 | 10.499.999 | 45.600 | 1 |
Total number of partners: 141
Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 132
Frequent / Rare Partner Ratio: 0.07
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2012-02-01 | Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer | RESPONSIFY | participant | 5.990.195 | 12 |
2012-02-01 | Enabling information re-Use by linking clinical REsearch and CAre | EURECA | participant | 9.651.000 | 20 |
2011-02-01 | Driving Excellence in Integrative Cancer Research through Innovative Biomedical Infrastructures | INTEGRATE | participant | 3.974.000 | 7 |
2010-07-01 | Breast Cancer Somatic Genetics Study | BASIS | participant | 10.499.999 | 15 |